drugset / Trial / NCT00042848

Modafinil in Treating Fatigue in Patients Receiving Chemotherapy for Cancer

NCT00042848

RandomizedDouble-blindSupportive care

Summary

RATIONALE: Modafinil may be effective in relieving fatigue in patients with cancer who are undergoing chemotherapy. The effectiveness of modafinil in relieving chemotherapy-related fatigue is not yet known. PURPOSE: This randomized phase III trial is studying the effectiveness of modafinil in treating fatigue in patients who are receiving chemotherapy for cancer.

Timeline

Start
2002-08
Primary completion
2007-04
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Modafinil Small molecule 200 mg Oral